PRISMEDICAL News
FOR IMMEDIATE RELEASE

Pazian Announcement Letter

We are very pleased to announce that Mr. Stephen E. Pazian has accepted an offer from the Board of Directors to become the Chief Executive Officer of PRISMEDICAL effective today. We are particularly pleased because of the wealth of experience Steve has in guiding smaller companies to greatness. His background as a CEO and as the marketing thought leader in several well-known companies and industries gives us great confidence that he will make contributions that will enable PRISMEDICAL to move forward successfully on several fronts.

The future success that we all want to see for PRISMEDICAL will, most certainly, be the result of cooperative efforts that involve all of you, the executive leadership of the company and the stockholders, as represented by the Board of Directors. As members of the Board of Directors, it remains our singular intent to support Steve, Mike and the entire team in pursuit of the opportunities that lay before us.

We hope that you will all welcome Steve and cooperate with his need to gain more knowledge about PRISMEDICAL and all of its attributes. He intends to arrive in the area on April 4th and come into the office on April 5th.

On behalf of the Board, we would like to thank each and everyone of you for your steadfast commitment to this company during this protracted interim period. We feel that a lot of good has been accomplished during this period that we can build on in the near future. We are also very grateful to Reed Prior and Bob Crane who have helped us through this time.

We wish you all the best of luck and look forward to seeing you soon.

Sincerely,

For the Board of Directors

Thomas C. Arland


About PRISMEDICAL CORPORATION

PRISMEDICAL CORPORATION was founded in 1996 with a vision to create new market opportunities in point-of-use water purification. PRISMEDICAL’s objective is to leverage its products to exploit gaps in conventional manufacture, distribution and supply of packaged medical fluids. Critical funding has been provided by grant awards from the Office of Naval Research. In 2002, PRISMEDICAL received FDA clearance to market its initial product, the Mainstream® Water Purification Device, a revolutionary product that enables health care workers to produce Sterile Purified Water, USP, at the point-of-need using only EPA grade tap water and gravity. Mainstream is currently used by the United States Marine Corps and other US Department of Defense customers. Following on the success of the Mainstream platform, PRISMEDICAL is launching its first consumer product, the Triton® Personal Water Purification Unit. Triton makes use of proprietary processes and redundant technologies to remove all classes of waterborne contaminants. PRISMEDICAL believes that because Triton operates by gravity only and can purify almost any non-brackish surface water available, it is uniquely positioned to capture significant share in the emergency preparedness, military and outdoor enthusiast markets.

TOP